212 related articles for article (PubMed ID: 34880754)
1. HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson's Disease.
Zhi Y; Sun Y; Jiao Y; Pan C; Wu Z; Liu C; Su J; Zhou J; Shang D; Niu J; Hua R; Yin P
Front Pharmacol; 2021; 12():754185. PubMed ID: 34880754
[No Abstract] [Full Text] [Related]
2. Metabolomic profiling of Wilson disease, an inherited disorder of copper metabolism, and diseases with similar symptoms but normal copper metabolism.
Qiu Y; Su M; Xiao X; Zhou D; Xie L
Orphanet J Rare Dis; 2023 Sep; 18(1):282. PubMed ID: 37697371
[TBL] [Abstract][Full Text] [Related]
3. Serum-Based Lipid Panels for Diagnosis of Idiopathic Parkinson's Disease.
Dahabiyeh LA; Nimer RM; Rashed M; Wells JD; Fiehn O
Metabolites; 2023 Sep; 13(9):. PubMed ID: 37755270
[TBL] [Abstract][Full Text] [Related]
4. Lipid metabolism and identification of biomarkers in asthma by lipidomic analysis.
Jiang T; Dai L; Li P; Zhao J; Wang X; An L; Liu M; Wu S; Wang Y; Peng Y; Sun D; Zheng C; Wang T; Wen X; Cheng Z
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Feb; 1866(2):158853. PubMed ID: 33160078
[TBL] [Abstract][Full Text] [Related]
5. The potential serum sphingolipid biomarkers for distinguishing Wilson disease.
Tang S; Liang C; Yu H; Hou W; Hu Z; Chen X; Duan Z; Zheng S
Clin Chim Acta; 2024 Jan; 553():117740. PubMed ID: 38145643
[TBL] [Abstract][Full Text] [Related]
6. Plasma lipidomics reveals potential lipid markers of major depressive disorder.
Liu X; Li J; Zheng P; Zhao X; Zhou C; Hu C; Hou X; Wang H; Xie P; Xu G
Anal Bioanal Chem; 2016 Sep; 408(23):6497-507. PubMed ID: 27457104
[TBL] [Abstract][Full Text] [Related]
7. LC-MS/MS based untargeted lipidomics uncovers lipid signatures of late-onset preeclampsia.
Yang Y; Wu L; Lv Y; Miao Z; Wang Y; Yan J; Li J; Li C; Ding H
Biochimie; 2023 May; 208():46-55. PubMed ID: 36496182
[TBL] [Abstract][Full Text] [Related]
8. Serum Untargeted UHPLC-HRMS-Based Lipidomics to Discover the Potential Biomarker of Colorectal Advanced Adenoma.
Zhu Y; Wang L; Nong Y; Liang Y; Huang Z; Zhu P; Zhang Q
Cancer Manag Res; 2021; 13():8865-8878. PubMed ID: 34858060
[TBL] [Abstract][Full Text] [Related]
9. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma.
Choi JM; Kim TE; Cho JY; Lee HJ; Jung BH
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():157-65. PubMed ID: 24316528
[TBL] [Abstract][Full Text] [Related]
10. Lipidomics Identified Lyso-Phosphatidylcholine and Phosphatidylethanolamine as Potential Biomarkers for Diagnosis of Laryngeal Cancer.
Yu B; Wang J
Front Oncol; 2021; 11():646779. PubMed ID: 34262857
[TBL] [Abstract][Full Text] [Related]
11. Serum untargeted lipidomics by UHPLC-ESI-HRMS aids the biomarker discovery of colorectal adenoma.
Zhou H; Nong Y; Zhu Y; Liang Y; Zhang J; Chen H; Zhu P; Zhang Q
BMC Cancer; 2022 Mar; 22(1):314. PubMed ID: 35331175
[TBL] [Abstract][Full Text] [Related]
12. [Nontargeted lipidomic analysis of sera from sepsis patients based on ultra-high performance liquid chromatography-mass spectrometry/mass spectrometry].
Wang S; Liang J; Shi H; Xia Y; Li J; Wu W; Wang H; Wu W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Apr; 34(4):346-351. PubMed ID: 35692196
[TBL] [Abstract][Full Text] [Related]
13. Lipidomics Profiling Reveals Serum Phospholipids Associated with Albuminuria in Early Type 2 Diabetic Kidney Disease.
Ye S; Hu YP; Zhou Q; Zhang H; Xia ZZ; Zhao SZ; Wang Z; Wang SY; Wang XY; Zhang YK; Chen ZD; Mao GY; Zheng C
ACS Omega; 2023 Oct; 8(39):36543-36552. PubMed ID: 37810655
[TBL] [Abstract][Full Text] [Related]
14. Untargeted Lipidomics Reveals Characteristic Biomarkers in Patients with Ankylosing Spondylitis Disease.
Li Z; Gu W; Wang Y; Qin B; Ji W; Wang Z; Liu S
Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672555
[No Abstract] [Full Text] [Related]
15. UHPLC-HRMS-based serum untargeted lipidomics: Phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancer.
Chen H; Zhou H; Liang Y; Huang Z; Yang S; Wang X; She Z; Wei Z; Zhang Q
J Pharm Biomed Anal; 2023 Sep; 234():115582. PubMed ID: 37473505
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.
Han YS; Chen JX; Li ZB; Chen J; Yi WJ; Huang H; Wei LL; Jiang TT; Li JC
Exp Biol Med (Maywood); 2021 Feb; 246(4):387-399. PubMed ID: 33175608
[TBL] [Abstract][Full Text] [Related]
17. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
[TBL] [Abstract][Full Text] [Related]
18. Lipid profiling in malignant mesothelioma reveals promising signatures for diagnosis and prognosis: A plasma-based LC-MS lipidomics study.
Chen Z; Song S; Yang C; Dai Z; Gao Y; Li N; Zhu J; Mao W; Liu J
Clin Chim Acta; 2022 Jan; 524():34-42. PubMed ID: 34843704
[TBL] [Abstract][Full Text] [Related]
19. Lipid Profiling Reveals Lipidomic Signatures of Weight Loss Interventions.
Lin K; Cheng W; Shen Q; Wang H; Wang R; Guo S; Wu X; Wu W; Chen P; Wang Y; Ye H; Zhang Q; Wang R
Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049623
[TBL] [Abstract][Full Text] [Related]
20. Lipidomics reveals the serum profiles of pediatric allergic rhinitis and its severity.
Li T; Dou Y; Ji J; Chen H; Zhu S; Wang M; Xiong Y; Wang Z; Shan J; Qian K; An L; Lin L; Wang S; Dai Q
Biomed Chromatogr; 2024 Jun; ():e5927. PubMed ID: 38866427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
